Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04NXR
|
||||
Former ID |
DIB005079
|
||||
Drug Name |
RO-16-8714
|
||||
Synonyms |
P-[(R)-3-[Bis-[(R)-beta-hydroxyphenethyl]amino]butyl]benzamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Diabetes [ICD9: 253.5, 588.1; ICD10:E23.2, N25.1] | Discontinued in Phase 1 | [544945] | ||
Structure |
Download2D MOL |
||||
Formula |
C27H32N2O3
|
||||
Canonical SMILES |
CC(CCC1=CC=C(C=C1)C(=O)N)N(CC(C2=CC=CC=C2)O)CC(C3=CC=CC<br />=C3)O
|
||||
InChI |
1S/C27H32N2O3/c1-20(12-13-21-14-16-24(17-15-21)27(28)32)29(18-25(30)22-8-4-2-5-9-22)19-26(31)23-10-6-3-7-11-23/h2-11,14-17,20,25-26,30-31H,12-13,18-19H2,1H3,(H2,28,32)
|
||||
InChIKey |
OPPQEWZOPDBGAS-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Beta-3 adrenergic receptor | Target Info | Modulator | [533155] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.